Molecular therapy oncolytics

Federal government websites often end in. The site is secure.

View the family homepage Submit Your Research. ASGCT members receive online subscriptions to the Molecular Therapy journals to stay up to date on the latest research in the field. Here's how to claim your subscription:. Claim Your Subscription. MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology. MTMCD focuses on advances in cell and gene therapy and how they are translated and applied in the clinical setting.

Molecular therapy oncolytics

Cell Press. How to publish in this journal. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 green comprises the quarter of the journals with the highest values, Q2 yellow the second highest values, Q3 orange the third highest values and Q4 red the lowest values. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents. This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

View Current Issue. Permissions Want to request permission to use information in Molecular Therapy? From bench to bedside: the history and progress of CAR T cell therapy.

.

Oncolytic viruses mediate antitumor responses through direct tumor cell lysis and induction of host antitumor immunity. However, the therapeutic efficacy of oncolytic viruses against malignant ascites has rarely been explored. This study aimed to evaluate the efficacy, safety, and immunomodulatory effect of an intraperitoneal injection of human type 5 recombinant adenovirus called H against malignant ascites. Forty patients with malignant ascites were recruited and treated with intraperitoneal H in the Fudan University Shanghai Cancer Center. The 4-week clinical responses were determined by an objective assessment of ascites volume change.

Molecular therapy oncolytics

Application in antiviral discovery and disinfection procedures. Conventional cancer treatments have limited effectiveness in many cases. Oncolytic therapy, based on the use of armed viruses directed against tumor cells, offers new perspectives in the fight against this global scourge.

Ice babo photos

Scope Molecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. Documents Year Value Non-citable documents 0 Non-citable documents 1 Non-citable documents 1 Non-citable documents 2 Non-citable documents 1 Non-citable documents 1 Non-citable documents 0 Non-citable documents 0 Non-citable documents 0 Citable documents 0 Citable documents 5 Citable documents 27 Citable documents 64 Citable documents 93 Citable documents Citable documents Citable documents Citable documents Going by its title, MTO technically encompasses any therapy that destroys cancer onco, from the Greek onkos , meaning lump or mass; lysis, from the Greek lusis , meaning breaking down. Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research research articles, conference papers and reviews in three year windows vs. Want to request permission to use information in Molecular Therapy? The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. How to publish in this journal. Read Molecular Therapy 's ethical statements on authorship, dual submission, competing interests, inclusion and diversity, and more. ASGCT members receive online subscriptions to the Molecular Therapy journals to stay up to date on the latest research in the field. Furthermore, to provide expert management and review of a broader diversity of submissions, we plan to expand the expertise of our editorial board and our associate editors. Year International Collaboration International Collaboration accounts for the articles that have been produced by researchers from several countries. Read Statements. No bacterial therapies have yet been approved, but there are numerous ongoing trials.

.

MTO: a new journal for a maturing field. Ethical Statements Read Molecular Therapy 's ethical statements on authorship, dual submission, competing interests, inclusion and diversity, and more. No bacterial therapies have yet been approved, but there are numerous ongoing trials. This site uses cookies to offer you a better user experience and to analyze site traffic. How to publish in this journal. SCImago Graphica Explore, visually communicate and make sense of data with our new data visualization tool. Mitra A. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address. It is an exciting time in cancer therapy, and with this journal rebranding, it is also an exciting time for Molecular Therapy Oncology. Cell Press. Want to request permission to use information in Molecular Therapy? MTO focuses on the development and testing of cancer therapies in pre-clinical and clinical settings, and provides a unique forum for work in the burgeoning fields of biologic cancer therapies including viral, bacterial, cellular, and gene therapy. Editorial Contacts Contact the editors-in-chief of each journal as well as Cell Press communications and advertising staff here. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'.